BIMERVAX XBB.1.16. COVID-19 Vaccine (recombinant, adjuvanted)
- Licence status
- Active substances
- SARS-CoV-2, variant XBB.1.16, spike protein, receptor binding domain fusion homodimer
- Dosage Form
- Emulsion for injection
- Licence number
- EU/1/22/1709/004-007
- Licence holder
- Hipra Human Health S.L.
Product documents
Licence information
- ATC code
- J07BN04 covid-19, protein subunit
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to medical prescription. • Official batch release In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 12/12/2024